| Auto injector with temperature control |
2023-1-24 |
2023-2-23 |
|
| Il-2 sequences and uses thereof |
2022-11-28 |
2023-1-01 |
|
| Auto injector with cartridge locking system |
2022-11-11 |
2023-3-09 |
|
| PTH prodrugs |
2022-10-20 |
2022-12-08 |
|
| Controlled-release cnp agonists with low npr-c binding |
2022-10-18 |
2022-12-01 |
|
| Prevention and treatment of ocular conditions |
2022-10-03 |
2023-4-13 |
|
| Auto injector with measurement of battery capacity left before re-charging is … |
2022-9-29 |
2023-4-06 |
|
| Auto injector with variable plunger force |
2022-9-21 |
2022-11-22 |
|
| Long-acting pth compound treatments |
2022-9-21 |
2023-3-30 |
|
| Controlled-release CNP agonists with reduced side-effects |
2022-8-30 |
2022-10-27 |
|
| Auto injector with adaptable air-shot mechanism |
2022-7-29 |
2023-1-19 |
|
| Controlled-release CNP agonists with increased NEP stability |
2022-7-26 |
2022-9-29 |
|
| Auto injector with detection of used cartridge and associated method |
2022-7-08 |
2022-9-06 |
|
| Conjugates undergoing intramolecular rearrangements |
2022-6-27 |
2022-8-01 |
|
| Hypoparathyroidism treatment |
2022-6-27 |
2022-8-01 |
|
| Cnp prodrugs |
2022-6-23 |
2023-4-13 |
|
| Prodrug Comprising a Drug-Linker Conjugate |
2022-6-23 |
2022-10-20 |
|
| Cnp prodrugs with carrier attachment at the ring moiety |
2022-6-16 |
2022-10-20 |
|
| Controlled-release cnp agonists with low initial npr-b activity |
2022-6-13 |
2023-4-06 |
|
| PTH compounds with low peak-to-trough ratios |
2022-6-06 |
2022-8-09 |
|
| Auto injector with charger safety |
2022-5-31 |
2022-9-15 |
|
| Lonapegsomatropin |
2022-5-12 |
2022-5-12 |
|
| Cnp prodrugs |
2022-4-18 |
2022-6-28 |
|
| Use of long-acting growth hormone for treating inflammation-induced diseases |
2022-3-31 |
2022-10-06 |
|
| Cnp prodrug with large carrier moiety |
2022-3-30 |
2022-6-14 |
|
| Incremental dose finding in controlled-release pth compounds |
2022-3-09 |
2022-5-31 |
|
| Combination therapy with controlled-release cnp agonists |
2022-1-23 |
2022-3-01 |
|
| Conjugates of π-electron-pair-donating heteroaromatic nitrogen-comprising … |
2021-12-15 |
2022-2-01 |
|
| Improvement of physical and mental well-being of patients with … |
2021-9-27 |
2022-3-31 |
|
| Improvement of physical and mental well-being of patients with … |
2021-9-27 |
2022-3-31 |
|
| Improvement of physical and mental well-being of patients with … |
2021-9-27 |
2022-3-31 |
|
| GLYCOSYLATED IL-2 PROTEINS AND THEIR USES |
2021-8-27 |
2022-11-23 |
|
| Glycosylated il-2 proteins and uses thereof |
2021-8-27 |
2022-5-16 |
|
| Long-acting growth hormone dosage forms with superior efficacy to daily … |
2021-8-26 |
2021-10-31 |
|
| Conjugates comprising reversible linkers and uses thereof |
2021-8-04 |
2022-2-10 |
|
| Dry pharmaceutical formulations of cnp conjugates |
2021-7-27 |
2021-9-30 |
|
| Liquid pharmaceutical formulations of pth conjugates |
2021-7-26 |
2021-9-30 |
|
| Sustained local drug levels for innate immune agonists |
2021-6-28 |
2021-8-31 |
|
| Induction of sustained local inflammation |
2021-6-28 |
2021-8-31 |
|
| Minimization of systemic inflammation |
2021-6-28 |
2021-8-31 |
|
| Conjugates of pattern recognition receptor agonists |
2021-6-28 |
2021-8-31 |
|
| NEW IL-2 SEQUENCES AND THEIR USES |
2021-6-02 |
2022-9-14 |
|
| Pegylated recombinant human growth hormone compounds |
2021-5-25 |
2021-8-20 |
|
| Hydrogel irradiation |
2021-5-03 |
2023-3-15 |
|
| Degradable hyaluronic acid hydrogels |
2021-3-21 |
2021-5-31 |
|
| Novel hydrogel conjugates |
2021-3-21 |
2021-5-31 |
|
| Polymeric Prodrugs with a Self-Immolative Linker |
2021-1-06 |
2021-9-16 |
|
| Conjugates undergoing intramolecular rearrangements |
2020-12-30 |
2023-4-13 |
|
| Biodegradable polyethylene glycol based water-insoluble hydrogels |
2020-10-07 |
2021-1-08 |
|
| Il-2 conjugates |
2020-9-24 |
2020-11-30 |
|
| Anti-ctla4 compounds with localized pk properties |
2020-6-19 |
2020-12-24 |
|
| Controlled-release tyrosine kinase inhibitor compounds with localized pk … |
2020-6-19 |
2020-12-24 |
|
| Anti-ctla4 conjugates |
2020-6-19 |
2020-12-24 |
|
| ANTI-CTLA4 CONJUGATES |
2020-6-19 |
2021-12-01 |
|
| Conjugates of an electron-donating nitrogen or tertiary amine comprising … |
2020-6-19 |
2022-9-29 |
|
| Controlled-release tyrosine kinase inhibitor compounds with localized pd … |
2020-6-19 |
2020-12-24 |
|
| Liquid pharmaceutical formulations of pth conjugates |
2020-6-19 |
2022-1-01 |
|
| Tyrosine kinase inhibitor conjugates |
2020-6-19 |
2020-12-24 |
|
| Anti-ctla4 compounds with localized pd properties |
2020-6-19 |
2020-12-24 |
|
| TYROSINE KINASE INHIBITOR CONJUGATES |
2020-6-19 |
2021-12-01 |
|
| Conjugates of heteroaromatic nitrogen-comprising compounds |
2020-6-19 |
2020-12-24 |
|
| Dry pharmaceutical formulations of cnp conjugates |
2020-6-19 |
2022-1-01 |
|
| Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier |
2020-5-05 |
2020-8-20 |
|
| PATTERN RECOGNITION RECEPTOR AGONIST CONJUGATES |
2020-1-03 |
2021-10-26 |
|
| PATTERN RECOGNITION RECEPTOR AGONIST CONJUGATES |
2020-1-03 |
2022-1-05 |
|
| SUSTAINED LOCAL DRUG LEVELS FOR INNATE IMMUNE AGONISTS |
2020-1-03 |
2021-10-26 |
|
| Auto injector with reconstitution handling support |
2019-12-09 |
2020-1-30 |
|
| Treatment of infections |
2019-9-25 |
2020-4-02 |
|
| Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
2019-9-22 |
2019-11-28 |
|
| Starting dose of pth conjugates. |
2019-5-17 |
2021-1-29 |
|
| Diagnosis, prevention and treatment of diseases of the joint |
2019-4-02 |
2019-6-30 |
|
| Conjugates |
2019-3-27 |
2019-10-03 |
|
| Dosage regimen for a controlled-release pth compound |
2019-3-25 |
2019-12-18 |
|
| Hydrogel-Linked IL-1ra Prodrug |
2019-1-28 |
2019-8-29 |
|
| Protecting Group Comprising a Purification Tag |
2018-7-03 |
2018-11-01 |
|
| Long-acting growth hormone dosage forms |
2018-3-19 |
2018-8-03 |
|
| PROCESS FOR THE PREPARATION OF A HYDROGEL, PRO-DRUG CONNECTED TO UMSUPORT AND … |
2017-8-22 |
2021-2-23 |
|
| Conjugation method for carrier-linked prodrugs |
2017-7-12 |
2018-12-20 |
|
| PTH Prodrugs |
2017-2-28 |
2022-3-25 |
|
| Carrier-Linked Treprostinil Prodrugs |
2017-1-27 |
2019-4-11 |
|
| Prevention and treatment of ocular conditions |
2017-1-06 |
2017-4-27 |
|
| Cnp prodrugs with carrier attachment at the ring moiety |
2017-1-05 |
2022-10-28 |
|
| Auto injector with adaptable air-shot mechanism |
2016-12-29 |
|
|
| Auto injector with cartridge retention system |
2016-12-29 |
|
|
| Auto injector with charger safety |
2016-12-29 |
|
|
| Auto injector with detection of used cartridge and associated method |
2016-12-29 |
|
|
| Auto injector with cartridge locking system |
2016-12-29 |
|
|
| Auto injector with temperature control |
2016-12-29 |
2022-10-28 |
|
| Front loaded auto injector for administering a medicament |
2016-12-29 |
|
|
| Auto injector with temperature control |
2016-12-29 |
|
|
| ULTRASONABLE POLYMER CONNECTIONS THROUGH A NON-ENZYMAL CONNECTOR WITH RATING … |
2016-10-27 |
2018-4-04 |
|
| Hydrogel linked prodrugs releasing modified drugs |
2016-8-12 |
2017-6-02 |
|
| Modified hydrogels |
2016-8-12 |
2017-6-02 |
|
| Prodrugs comprising a pyroglutamate linker |
2016-5-25 |
2022-4-12 |
2022-4-12 |
| Carrier-linked prostanoid prodrugs |
2016-3-21 |
2016-10-21 |
|
| Auto-injecteur avec mesure de capacité de batterie restante avant recharge |
2022-9-29 |
2023-4-06 |
|
| Amelioration du bien-etre physique et mental de patients atteints … |
2021-9-27 |
2022-3-31 |
|
| Níveis de fármaco locais sustentados para agonistas imunes inatos |
2020-1-03 |
2021-10-26 |
|
| Conjugados de agonistas de receptor de reconhecimento de padrão |
2020-1-03 |
2021-10-26 |
|